Domestic new crown vaccines are up to standard and can only be approved for marketing after they are up to standard. The domestic new crown vaccines that are already on the market are already up to standard and have gone through rigorous clinical validation as well as experimental analysis. There are three main types of vaccines currently on the market in China, namely inactivated vaccines, recombinant immunization vaccines, and adenovirus vector vaccines. The inactivated vaccine requires two doses at intervals greater than or equal to 3 weeks, and the protection rate can reach 91.25%. The recombinant immune vaccine requires three doses, with a recommended interval of 4 weeks or more between each dose, and 97% of people can develop neutralizing antibodies after three doses of the vaccine. The adenovirus vector vaccine requires only one dose and has an overall protection rate of 74.8%. Either of the domestic vaccines is safe and can be administered with confidence.